Key facts
- KalVista's Chief Development Officer sold 33,800 shares.
- The total value of the shares sold was $905,000.
Insider selling can sometimes be interpreted as a signal of a lack of confidence in a company's future prospects, although it can also be for personal financial reasons. This sale by a key executive at KalVista is notable given the company's focus on drug development.